Response to CMA update
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
Following the announcement by the Competition and Markets Authority ("CMA") this morning, CVS notes the commencement by the CMA of a consultation on a proposal to make a market investigation reference in relation to veterinary services for household pets in the UK.
CVS has engaged constructively and proactively with the CMA throughout its review. As the announcement today cites, CVS along with certain other corporate groups who together own around 50% of First Opinion Practices ("FOPs") in the UK, has already engaged constructively with the CMA and put forward a package of possible remedies to address its concerns. CVS continues to believe this package could be adopted across the market and could address the CMA's concerns more quickly than an 18-month investigation.
CVS will continue to work proactively with the CMA as the consultation progresses up until 11 April 2024. We look forward to the CMA announcing a further update subsequent to that.
CVS Group plc via Camarco
Richard Fairman, CEO
Ben Jacklin, Deputy CEO
Robin Alfonso, CFO
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / James Thompson / Milo Bonser
Camarco (Financial PR)
Ginny Pulbrook +44 (0)7961 315 138
Geoffrey Pelham-Lane +44 (0)7733 124 226
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.